RecallDepth
Class II Terminated

Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mL (100 mcg/0.1 mL) 1 mL syringes, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

This recall has been terminated (originally issued October 25, 2023).

Company
Pine Pharmaceuticals, Llc
Recall Initiated
October 2, 2023
Posted
October 25, 2023
Recall Number
D-0058-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2176 syringes
Firm Location
Tonawanda, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of Assurance of Sterility

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: 67623, Exp. Date 10/15/2023; 67919, Exp. Date 10/29/2023; 68917, Exp. Date 12/16/2023; 69079, Exp. Date 12/23/2023; 69120, Exp. Date 12/24/2023

More recalls by Pine Pharmaceuticals, Llc

View all recalls by this company →

Other recent Class II Drug recalls